Effect of patient morphology on dosimetric calculations for internal irradiation as assessed by comparisons of Monte Carlo versus conventional methodologies

Journal of Nuclear Medicine

Volumn 50, Issue 2, 2009, Pages 316-323

  Divoli, Antigoni ^a,d   Chiavassa, Sophie ^b,c   Ferrer, Ludovic ^b   Barbet, Jacques ^b   Flux, Glenn D ^a   Bardiès, Manuel ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b Team 12   (France)

^c CHD Les Oudairies   (France)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Dosimetry; Internal radiation; Patient specific dosimetry; Radionuclide therapy

Indexed keywords

IODINE 131; RADIOISOTOPE;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DENSITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOSIMETRY; HUMAN; INTERMETHOD COMPARISON; IRRADIATION; MALE; MATHEMATICS; METHODOLOGY; MONTE CARLO METHOD; MORPHOLOGY; NUCLEAR MEDICINE; ORGAN; PHANTOM; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION PROTECTION; S FACTOR CALCULATION; SELF CONCEPT; TUMOR;

ADULT; AGED; BODY HEIGHT; BODY SIZE; BODY WEIGHT; HUMANS; MALE; MIDDLE AGED; MODELS, ANATOMIC; MONTE CARLO METHOD; NEOPLASMS; ORGAN SIZE; PHANTOMS, IMAGING; RADIOMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 59249109350     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.056705     Document Type: Article

References (25)

1. Loevinger R, Budinger TF, Watson EE. MIRD Primer for Absorbed Dose Calculations. Rev ed. New York, NY: Society of Nuclear Medicine; 1991.
2. Cristy M, Eckerman KF. Specific Absorbed Fractions of Energy at Various Ages from Internal Photon Sources. ORNL/NUREG/TM-8381/V1. Oak Ridge, TN: Oak Ridge National Laboratories; 1987.
3. Stabin MG, Watson EE, Cristy M, et al. Mathematical Models and Specific Absorbed Fractions of Photon Energy in the Nonpregnant Adult Female and at the End of Each Trimester of Pregnancy. ORNL/TM-12907. Oak Ridge, TN: Oak Ridge National Laboratories; 1995.
4. Howell RW, Wessels BW, Loevinger R. The MIRD perspective. J Nucl Med. 1999;40(suppl):3S-10S.
5. Williams LE, Liu A, Yamauchi DM, Lopatin G, Raubitschek AA, Wong JYC. The two types of correction of absorbed dose estimates for internal emitters. Cancer. 2002;94:1231-1234.
6. Petoussi-Henss N, Bolch WE, Zankl M, Sgouros G, Wessels B. Patient-specific scaling of reference S-values for cross-organ radionuclide S-values: what is appropriate? Radiat Prot Dosimetry. 2007;127:192-196.
7. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027.
8. Stabin MG. Uncertainties in internal calculations for radiopharmaceuticals. J Nucl Med. 2008;49:853-860.
9. Bardiès M, Kwok C, Sgouros G. Dose point-kernels for radionuclide dosimetry. In: Zaidi H, Sgouros G, eds. Therapeutic Applications of Monte Carlo Calculations in Nuclear Medicine. Philadelphia, PA: IOP Publishing; 2003:158-174.
10. Ferrer L, Chouin N, Bitar A, Lisbona A, Bardiès M. Implementing dosimetry in gate: dose-point kernel validation with GEANT4 4.8.1. Cancer Biother Radiopharm. 2007;22:125-129.
11. Giap HB, Macey DJ, Bayouth JE, Boyer AL. Validation of a dose-point kernel convolution technique for internal dosimetry. Phys Med Biol. 1995;40:365-381.
12. Akabani G, Hawkins WG, Eckblade MB, Leichner PK. Patient-specific dosimetry using quantitative SPECT imaging and three-dimensional discrete Fourier transform convolution. J Nucl Med. 1997;38:308-314.
13. Bolch WE, Bouchet LG, Robertson JS, et al. MIRD pamphlet no. 17: the dosimetry of nonuniform activity distributions - radionuclide S values at the voxel level. J Nucl Med. 1999;40(suppl):11S-36S.
14. Yoriyaz H, Santos A, Stabin MG, Cabezas R. Absorbed fractions in a voxel-based phantom calculated with the MCNP-4B code. Med Phys. 2000;27:1555-1562.
15. Descalle M, Christine L, Hartmann S, et al. Application of MINERVA Monte Carlo simulations to targeted radionuclide therapy. Cancer Biother Radiopharm. 2003;18:71-79.
16. 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation. J Nucl Med. 2005;46:840-849.
17. 124I PET and 3-dimensional internal dosimetry software. J Nucl Med. 2007;48:143-149.
18. Zaidi H. Relevance of accurate Monte Carlo modelling in nuclear medical imaging. Med Phys. 1999;26:574-608.
19. Chiavassa S, Aubineau-Laniece I, Bitar A, et al. Validation of a personalized dosimetric evaluation tool (Oedipe) for targeted radiotherapy based on the Monte Carlo MCNPX code. Phys Med Biol. 2006;51:601-616.
20. Chiavassa S, Bardiès M, Guiraud-Vitaux F, et al. OEDIPE: a personalised dosimetric tool associating voxel-based models with MCNPX. Cancer Biother Radiopharm. 2005;20:325-332.
21. Hendricks JS, McKinney GW, Waters LS, et al. MCNPX, Version 2.5.e. LA-UR-04-0569. Los Alamos, NM: Los Alamos National Laboratory; 2004.
22. International Commission on Radiation Units and Measurements (ICRU). Tissue Substitutes in Radiation Dosimetry and Measurement. ICRU Report 44. Bethesda, MD: ICRU; 1989.
23. International Commission on Radiological Protection (ICRP). Radionuclide Transformations: Energy and Intensity of Emissions. ICRP Publication 38. New York, NY: Pergamon Press; 1983.
24. 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma. Blood. 2004;104:642-648.
25. Liu A, Williams LE, Wong JYC, Raubitschek AA. Monte Carlo-assisted voxel source kernel method (MAVSK) for internal beta dosimetry. Nucl Med Biol. 1998;25:423-433.